Generare

Paris, France

Generare is a biotech startup that discovers next-generation medicines and high-value molecules hiding in soil bacteria.

$5.5M raised

Apr 2026

Series A

Top Investors

DaphniAlvenTeampact venturesGalion.exeBetter Angle

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Generare raised?

Generare has raised $5.5M in total funding. The most recent round was Series A. The last funding was announced in April 2026.

Who are Generare's investors?

Generare's investors include Daphni, Alven, Teampact ventures, Galion.exe, Better Angle.

Where is Generare headquartered?

Generare is headquartered in Paris, France.

What does Generare do?

Generare is a biotech startup that discovers next-generation medicines and high-value molecules hiding in soil bacteria.

What stage is Generare at?

Generare is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 2, 2026.

MLA

"Generare — Funding & Investors." VCBacked, April 2, 2026, https://www.vcbacked.co/company/generare. Accessed June 4, 2026.

APA

VCBacked. (2026). Generare — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/generare

Wikipedia (cite web)

{{cite web |title=Generare — Funding & Investors |url=https://www.vcbacked.co/company/generare |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 2, 2026.